Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine

被引:54
作者
Taler, SJ
Textor, SC
Canzanello, VJ
Schwartz, L
Porayko, M
Wiesner, RH
Krom, RA
机构
[1] Division of Hypertension, Mayo Clinic, Rochester
关键词
D O I
10.1097/00007890-199612150-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transplant immunosuppression using either cyclosporine (CsA) or tacrolimus (FK506) leads to renal vasoconstriction and nephrotoxicity. Despite producing similar effects within the kidney and blood vessels, clinical hypertension occurs less frequently with tacrolimus during the first year after transplantation, compared with CsA. To examine the role of steroid dose in early posttransplant hypertension, we measured blood pressure and kidney function in liver transplant recipients treated with tacrolimus and either high-dose (TAC-HI-P, n = 19) or low-dose (TAC-LO-P, n = 20) prednisone, compared with CsA-treated recipients (n = 29) receiving prednisone doses similar to the TAC-HI-P group. At 1 month, hypertension occurred more often with CsA (72%) than with TAC-HI-P (42%, P < 0.05) or TAC-LO-P (30%, P < 0.05). By 4 months after transplantation, hypertension developed in nearly twice as many TAC-HI-P (63%) as TAC-LO-P patients (32%, P < 0.05), with no difference between TAC-HI-P and CsA (86%, NS). Daily prednisone dose at 1 month closely paralleled cumulative steroid dose in the first month in the TAC-HI-P and TAC-LO-P groups. Fourteen of 19 TAC-HI-P patients (74%) required bolus steroids for treatment of rejection within the first month, compared with 3/20 (15%) TAC-LO-P and 10/29 (34%) CsA recipients. Glomerular filtration rate fell from pretransplant levels at 1 month and 4 months to the same degree in CsA, TAC-HI-P, and TAC-LO-P patients. These results demonstrate a central role for steroid dose in the rate of onset of hypertension early after liver transplantation using tacrolimus immunosuppression. Both daily dose and cumulative dosage, including bolus treatment for rejection, may impact on the development of hypertension. Since prevalence rates rise to levels comparable to CsA by 24 months regardless of steroid dose, hypertension after liver transplant may be mediated by different mechanisms at different stages of the posttransplant course.
引用
收藏
页码:1588 / 1592
页数:5
相关论文
共 16 条
[1]  
CANZANELLO VJ, 1995, J AM SOC NEPHROL, V5, P1910
[2]  
*EUR FK506 MULT LI, 1994, LANCET, V344, P423
[3]   THE 1ST 100 LIVER TRANSPLANTATIONS AT THE MAYO CLINIC [J].
KROM, RAF ;
WIESNER, RH ;
RETTKE, SR ;
LUDWIG, J ;
SOUTHORN, PA ;
HERMANS, PE ;
TASWELL, HF .
MAYO CLINIC PROCEEDINGS, 1989, 64 (01) :84-94
[4]   PRESSOR RESPONSIVENESS IN CORTICOSTEROID-INDUCED HYPERTENSION IN HUMANS [J].
PIRPIRIS, M ;
SUDHIR, K ;
YEUNG, S ;
JENNINGS, G ;
WHITWORTH, JA .
HYPERTENSION, 1992, 19 (06) :567-574
[5]   NEPHROTOXIC EFFECTS OF PRIMARY IMMUNOSUPPRESSION WITH FK-506 AND CYCLOSPORINE REGIMENS AFTER LIVER-TRANSPLANTATION [J].
PORAYKO, MK ;
TEXTOR, SC ;
KROM, RAF ;
HAY, JE ;
GORES, GJ ;
RICHARDS, TM ;
CROTTY, PH ;
BEAVER, SJ ;
STEERS, JL ;
WIESNER, RH .
MAYO CLINIC PROCEEDINGS, 1994, 69 (02) :105-111
[6]   GLUCOCORTICOID-INDUCED HYPERTENSION IN THE ELDERLY - RELATION TO SERUM-CALCIUM AND FAMILY HISTORY OF ESSENTIAL-HYPERTENSION [J].
SATO, A ;
FUNDER, JW ;
OKUBO, M ;
KUBOTA, E ;
SARUTA, T .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (08) :823-828
[7]   SYSTEMIC AND RENAL HEMODYNAMIC DIFFERENCES BETWEEN FK506 AND CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS [J].
TEXTOR, SC ;
WIESNER, R ;
WILSON, DJ ;
PORAYKO, M ;
ROMERO, JC ;
BURNETT, JC ;
GORES, G ;
HAY, E ;
DICKSON, ER ;
KROM, RA .
TRANSPLANTATION, 1993, 55 (06) :1332-1339
[8]  
TEXTOR SC, 1994, CIRCULATION, V90, P73
[9]   URINARY ENDOTHELIN AND RENAL VASOCONSTRICTION WITH CYCLOSPORINE OR FK506 AFTER LIVER-TRANSPLANTATION [J].
TEXTOR, SC ;
BURNETT, JC ;
ROMERO, JC ;
CANZANELLO, VJ ;
TALER, SJ ;
WIESNER, R ;
PORAYKO, M ;
KROM, R ;
GORES, G ;
HAY, E .
KIDNEY INTERNATIONAL, 1995, 47 (05) :1426-1433
[10]  
TEXTOR SC, 1994, J AM SOC NEPHROL, V5, P1223